Labour market participation after a sickness absence due to cancer: a dynamic cohort study in Catalonia (Spain)

Abstract

Background: Consequences of cancer on working life until retirement age remain unclear. This study aimed to compare labour market participation patterns in workers with a sickness absence (SA) due to cancer versus those with no SA and those with SA due to other diseases. Methods: Registry-based cohort study of social security affiliates in Catalonia from 2012-2018. Cases consisted of workers with SA due to cancer between 2012-2015 (N=516) and were individually age- and sex-matched with an affiliate with SA due to other diagnoses and a worker without SA. All workers (N=1,548, 56% women) were followed-up until the end of 2018. Sequence analysis, optimal matching, and multinomial logistic regression were used to identify and assess the probability of future labour market participation patterns (LMPP). All analyses were stratified by sex. Results: Compared with workers with SA due to cancer, male workers without SA and SA due to other causes showed lower probability of being in the LMPP of death (aRRR 0.02, 95% CI: 0.00‒0.16; aRRR 0.17, 95% CI: 0.06‒0.46, respectively), and in women lower probability of increasing permanent disability and death (aRRR 0.24, 95% CI: 0.10‒0.57; aRRR 0.39, 95% CI: 0.19‒0.83). Compared to workers with SA due to cancer, risk of future retirement was lower in workers with no SA (women aRRR 0.60, 95% CI: 0.22‒1.65; men aRRR 0.64, 95%CI: 0.27‒1.52). Conclusions Workplaces should be modified to the needs of cancer survivors in order to prevent more frequent early exit of labour market due to retirement and permanent disability when possible.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by Health Institute Carlos III- FIS_FEDER

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Parc de Salut Mar Ethics Committee in Barcelona (Research Protocol no. 2020/9119) and was exempted from informed consent requirements owing to its registry-based design

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

留言 (0)

沒有登入
gif